IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
36.74
+0.45 (1.24%)
At close: Jun 26, 2026, 4:00 PM EDT
36.00
-0.74 (-2.01%)
After-hours: Jun 26, 2026, 6:30 PM EDT
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for IDEAYA Biosciences stock have an average target of 54, with a low estimate of 36 and a high estimate of 66. The average target predicts an increase of 46.98% from the current stock price of 36.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IDEAYA Biosciences stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 13 | 13 | 13 | 13 | 11 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 18 | 18 | 18 | 18 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $30 → $50 | Buy | Maintains | $30 → $50 | +36.09% | Jun 16, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $65 → $62 | Buy | Maintains | $65 → $62 | +68.75% | Jun 15, 2026 |
| Wedbush | Wedbush | Buy Reiterates $58 | Buy | Reiterates | $58 | +57.87% | Jun 12, 2026 |
| UBS | UBS | Buy Reiterates $50 | Buy | Reiterates | $50 | +36.09% | Jun 9, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $35 → $36 | Hold | Maintains | $35 → $36 | -2.01% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
33.99M
from 218.71M
Decreased by -84.46%
Revenue Next Year
116.80M
from 33.99M
Increased by 243.65%
EPS This Year
-4.31
from -1.28
EPS Next Year
-3.66
from -4.31
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 85.5M | 242.5M | |
| Avg | 34.0M | 116.8M | |
| Low | n/a | 17.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -60.9% | 613.3% | |
| Avg | -84.5% | 243.7% | |
| Low | -100.0% | -47.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.63 | -1.29 | |
| Avg | -4.31 | -3.66 | |
| Low | -5.00 | -4.56 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.